Objectives: To study Vitamin D levels and bone age estimation in patients with thalassemia major and to correlate various factors associated with short stature, Vitamin D deficiency and bone age difference. Study Design: Prospective observational study Setting: Thalassemia clinic, Civil hospital, Ahmedabad Subjects and intervention: Total 84 patients with Beta-thalassemia major less than 12 years of age during 1 month period were included after taking informed consent. Study period: 15 October 2016 to 15 November 2016 Results: Out of 84 patients 34 patients had Vitamin D deficiency(<20ng/ml), 34 patients had short stature and 24 patients with bone age >36 months had age>10 years. Vitamin D levels <30ng/ml is associated with ferritin level >2500(mcg/l)(OR=2.23 p=0.02 95%CI). Age>10 year(OR=7.7 P=0.0001 95%CI) and ferritin >2500mcg/l (OR=1.9 P=0.1 95%CI)are associated with bone age difference>36 months. Increased S.ALP(OR=1.1 P=0.02 95%CI) and ferritin levels>2500 mcg/l (OR:3.6 P=0.0056 95% CI )are associated with short stature. Conclusion: Vitamin D and calcium supplementation along with disciplined transfusion and chelation regimen can likely prevent or delay late complications like short stature, osteoporosis in thalassemia patients.
INTRODUCTION:
Thalassemia is a disease of the blood in which there is increased destruction (hemolysis) of the red cells. Thalassemia major is severe form in which the patient needs regular blood transfusions in order to survive while thalassemia minor an asymptomatic carrier state with patients of thalassemia intermedia in between.
[1]
Certain communities in India, like Punjabis,gujarati,sindhis and Bengalis, are more commonly affected with beta thalassemia, the incidence varying from 1 to 17% [2] .
Estimatation that the prevalence of pathological hemoglobinopathies in India is 1.2/1,000 live births [3] , and with approximately 27 million births per year [4] this would suggest the annual birth of 32,400 babies with a serious hemoglobin disorder Vitamin D deficiency and bone age difference frequently present in children with thalassemia major despite regular multiple blood transfusions and optimal chelation. There is a Scarcity of indian studies in children <12 years of age regarding vitamin D levels and bone age in Thalassemia major.
METHODOLOGY:
This prospective observational study was conducted at the Pediatric Thalassemia Clinic of Civil Hospital Ahmedabad during 15 October 2016 to 15 november 2016. The inclusion criteria were Patients with thalassemia major less than 12 years of age and patients receiving regular blood transfusion and chelation. We excluded patients >12 years of age. We performed physical examination, serum ferritin measurement, and bone age examination. A child was diagnosed as short stature if the height was below third percentile on National Center for Chronic Disease Prevention and Health Promotion (CDC) 2000 curve. association between each variable was analyzed with odd's ratio.
RESULTS:
Out of total 84 patients 40 (47%) were male and 44 (52%) were female. Mean age of starting blood transfusion was 13.5± 6(months),mean age of starting of iron chelation therapy was 4.5± 3.2(years),mean pretransfusion Hb in last year was 9.3±2.8(g/dl),mean Ferritin levels was 2486±1856 (μg/l) and mean total years of blood transfusion were 6.4±3.4. . Out of 84 patients 24 were in < 5 year age group,24 patients in 5-10 year age group while 38 patients in >10 year age group. 12(14%) of our patients had normal (>30ng/ml) Vitamin D 34(40%) had Vitamin D deficiency(<20 ng/ml) and the rest 38(48%) had vitamin D insufficiency(20-30ng/ml). From 72(86%) patients with bone age deficit , 34(44%) had bone age difference >36 months from that 28(75%) were >10 years of age.(OR=4.5 P=0.001 95%CI)and 24(64%) patients have ferritin >2500(μg/l)(OR=1.9 P= 0.1 95%CI). 
DISCUSSION:
Out of 84 patients 34 patients had Vitamin D deficiency(<20ng/ml), 34 patients had short stature and 24 patients with bone age >36 months had age>10 years.
Vitamin D levels <30ng/ml is associated with ferritin level >2500(mcg/l)(OR=2.23 p=0.02 95%CI)
Age>10 year(OR=7.7 P=0.0001 95%CI) and ferritin >2500mcg/l (OR=1.9 P=0.1 95%CI)are associated with bone age difference>36 months.
Increased S.ALP(OR=1.1 P=0.02 95%CI) and ferritin levels>2500 mcg/l (OR:3.6 P=0.0056 95% CI )are associated with short stature.
High mean ferritin levels,High mean age at iron chelation started and total years of blood transfusion correleted significantly with short stature and bone age difference >36 months.
Vitamin D deficiency with increased S.ALP is more prevalent in >10 years age group where as Vitamin D insufficiency with hypocalcaemia present more in 5-10 year age group.Increased alkaline phosphatase and Hypocalcaemia can be used to predict Vitamin D deficiency in centers where tests for vitamin D can't be done.Short stature, Vitamin D deficiency and bone age difference known to have multiple causes. Evaluating and Excluding all those was not possible.Most patients were on Calcium supplementation. So actual deficiency can be greater.There are several factors that influences serum ferritin level, such as acute infection due to bacterial or virus, or vitamin C deficiency. More iron overload leads to more severe bone disturbance. Other studies also found that bone age disturbance in patients with thalassemia is caused by iron overload. [7] Study that observed the association between serum ferritin level and growth retardation in thalassemic patients showed that mean serum ferritin level in group with short stature is higher than in those with normal stature. [8] Other studies showed Subjects with bone age difference <36 months mostly had serum ferritin level <5,000 ng/dL, while most subjects with bone age difference >36 months had serum ferritin level =5,000 ng/dL.
[9]
CONCLUSION:
Vitamin D and calcium supplementation along with disciplined transfusion and chelation regimen can likely prevent or delay late complications like short stature, osteoporosis in thalassemia patients
